BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10932146)

  • 1. Imaging Alzheimer's amyloid.
    Selkoe DJ
    Nat Biotechnol; 2000 Aug; 18(8):823-4. PubMed ID: 10932146
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical.
    Lee HJ; Zhang Y; Zhu C; Duff K; Pardridge WM
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):223-31. PubMed ID: 11823720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's theory makes a splash.
    Schnabel J
    Nature; 2009 May; 459(7245):310. PubMed ID: 19458681
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain amyloid in Alzheimer's disease--a new experimental model.
    Pavlin R
    Neurol Croat; 1992; 41(4):227-34. PubMed ID: 1463806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Alzheimer's disease.
    McGeer PL; McGeer E
    Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
    Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
    Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice.
    LaFerla FM; Tinkle BT; Bieberich CJ; Haudenschild CC; Jay G
    Nat Genet; 1995 Jan; 9(1):21-30. PubMed ID: 7704018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bad seed in Alzheimer's disease.
    Fryer JD; Holtzman DM
    Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease and amyloid beta-protein].
    Ikeda S
    No To Shinkei; 1989 Nov; 41(11):1051-64. PubMed ID: 2515890
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD.
    Lewis HD; Beher D; Smith D; Hewson L; Cookson N; Reynolds DS; Dawson GR; Jiang M; Van der Ploeg LH; Qian S; Rosahl TW; Kalaria RN; Shearman MS
    Neurobiol Aging; 2004 Oct; 25(9):1175-85. PubMed ID: 15312963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.